Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations
Based on the recommendations of the European Heart Society and the results of clinical and register studies, the article highlights the complex issues that arise when prescribing antiplatelet therapy in patients with acute coronary syndrome, including with concomitant atrial fibrillation (AF); the p...
Main Authors: | V. V. Kashtalap, O. L. Barbarash |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-04-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2910 |
Similar Items
-
ACTUAL PROBLEMS OF ANTITOMBOTIC THERAPY IN ACUTE CORONARY SYNDROME (FOLLOWING THE MATERIAL PRESENTED AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2017)
by: V. V. Kashtalap, et al.
Published: (2017-11-01) -
A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel
by: V. V. Kashtalap, et al.
Published: (2019-10-01) -
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
by: Sychev DA, et al.
Published: (2020-01-01) -
THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
by: S. R. Gilyarevsky, et al.
Published: (2014-07-01) -
THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
by: S. R. Gilyarevsky, et al.
Published: (2014-07-01)